Kostas M, Munthe E, Haugsten EM, Mateus D, Sørensen V, Laerdahl JK, Szybowska P, Wiedlocha A, Lecaudey LA, Nakken S, Schink KO, Stenmark H, Wesche J (2026)
Unconventional activation of the proto-oncogene FGFR1 by extracellular phosphate via H₂O₂-mediated kinase oxidation
Cell Rep, 45 (6), 117504 (in press)
DOI 10.1016/j.celrep.2026.117504, PubMed 42247296

Myklebust JH (2026)
Predicting and reversing T-cell engager resistance
Blood, 147 (23), 2704-2705
DOI 10.1182/blood.2026033471, PubMed 42241044

Nunes-Xavier CE, Rodríguez-Ramos A, Pulido R (2026)
β-catenin at the crossroads of cancer and neurodevelopment
Trends Cancer (in press)
DOI 10.1016/j.trecan.2026.05.001, PubMed 42215419

Myklebust JH (2026)
Predicting and reversing T-cell engager resistance
Blood, 147 (23), 2704-2705
DOI 10.1182/blood.2026033471, PubMed 42241044

Kostas M, Munthe E, Haugsten EM, Mateus D, Sørensen V, Laerdahl JK, Szybowska P, Wiedlocha A, Lecaudey LA, Nakken S, Schink KO, Stenmark H, Wesche J (2026)
Unconventional activation of the proto-oncogene FGFR1 by extracellular phosphate via H₂O₂-mediated kinase oxidation
Cell Rep, 45 (6), 117504 (in press)
DOI 10.1016/j.celrep.2026.117504, PubMed 42247296

Ree AH, Meltzer S, Flatmark K, Dueland S (2026)
Low-intensity induction chemotherapy before chemoradiotherapy for rectal cancer: 10-year overall survival in the LARC-RRP trial
Br J Radiol (in press)
DOI 10.1093/bjr/tqag133, PubMed 42233285